Quest Diagnostics (DGX) Tops Q1 EPS by 2c
Tweet
Share
E-mail
Get Alerts DGX Hot Sheet
Price: $237.14 -0.94%
Revenue Growth %: +7.8%
Financial Fact:
Other (expense) income, net: 4M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Revenue Growth %: +7.8%
Financial Fact:
Other (expense) income, net: 4M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Quest Diagnostics (NYSE: DGX) reported Q1 EPS of $1.52, $0.02 better than the analyst estimate of $1.50. Revenue for the quarter came in at $1.88 billion versus the consensus estimate of $1.9 billion.
- Outlook for full year 2018 remains unchanged
For earnings history and earnings-related data on Quest Diagnostics (DGX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- EU proposes to curb Airbnb and short-term rentals amid housing shortage
- John Wiley & Sons, Inc. (WLYB) Misses Q1 EPS by 2c ; Offers Guidance
- Dell’s earning report was bullish for Intel CPU demand, analyst says
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
